Patents by Inventor Ryan WAGNER
Ryan WAGNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12538995Abstract: A shower curtain closure device for automatically closing a shower curtain includes a housing having a front side, a back side, and a peripheral wall extending therebetween, defining an interior space. The front side has a shower rod recess therein that is configured to receive a portion of a shower curtain rod. A spool is positioned within the interior space. A cord having a spool end and a clip end is coupled to the housing. The spool end is attached to the spool and the cord is wrapped around the spool. The spool rotates to wrap and unwrap the cord, such that the cord retracts into and extends from the housing. A curtain clip is attached to the clip end that can removably engage a shower curtain ring. A motor is positioned within the interior space. The motor is coupled to the spool, rotating the spool to retract the cord.Type: GrantFiled: August 25, 2023Date of Patent: February 3, 2026Inventor: Ryan Wagner
-
Patent number: 12429391Abstract: Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.Type: GrantFiled: April 5, 2022Date of Patent: September 30, 2025Assignee: Purdue Research FoundationInventors: Dan Feng, Ryan Wagner, Arvind Raman
-
Patent number: 12429390Abstract: Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.Type: GrantFiled: April 5, 2022Date of Patent: September 30, 2025Assignee: Purdue Research FoundationInventors: Dan Feng, Ryan Wagner, Arvind Raman
-
Publication number: 20250064249Abstract: A shower curtain closure device for automatically closing a shower curtain includes a housing having a front side, a back side, and a peripheral wall extending therebetween, defining an interior space. The front side has a shower rod recess therein that is configured to receive a portion of a shower curtain rod. A spool is positioned within the interior space. A cord having a spool end and a clip end is coupled to the housing. The spool end is attached to the spool and the cord is wrapped around the spool. The spool rotates to wrap and unwrap the cord, such that the cord retracts into and extends from the housing. A curtain clip is attached to the clip end that can removably engage a shower curtain ring. A motor is positioned within the interior space. The motor is coupled to the spool, rotating the spool to retract the cord.Type: ApplicationFiled: August 25, 2023Publication date: February 27, 2025Inventor: Ryan Wagner
-
Publication number: 20240027290Abstract: Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.Type: ApplicationFiled: April 5, 2022Publication date: January 25, 2024Inventors: Dan Feng, Ryan Wagner, Arvind Raman
-
Publication number: 20240027291Abstract: Systems and methods for measuring web tension distribution in roll-to-roll processes, for example, such as R2R processes employed in the fabrication of printed devices. Such systems and methods entail a web that travels between first and second rollers in a longitudinal direction of the web, inducing tension in the web in the longitudinal direction thereof such that tension is present in a flexible substrate of the web between the first and second rollers, and operating the system to determine an average tension and linear variation of tension present in the flexible substrate resulting from the tension induced in the web inducing a nonuniform tension distribution in the flexible substrate between the first and second rollers. The systems and methods utilize one or more devices that induce deflection in the web between the first and second rollers.Type: ApplicationFiled: April 5, 2022Publication date: January 25, 2024Inventors: Dan Feng, Ryan Wagner, Arvind Raman
-
Publication number: 20210338585Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: ApplicationFiled: July 15, 2021Publication date: November 4, 2021Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Ryan Wagner, Aareet Mahadevan, Abdel Rahman Elsayed, Juewen Liu
-
Publication number: 20190374469Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: ApplicationFiled: April 15, 2019Publication date: December 12, 2019Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Ryan Wagner, Aareet Ganesh Shermon, Abdel Rahman Elsayed, Juewen Liu
-
Patent number: 10352837Abstract: An optomechanical reference includes a basal member; a flexure that includes: a floating link; a first flexural member; and a second flexural member such that: the floating link is moveably disposed; a first stator; a second stator; a first cavity including: a first primary mirror; a first secondary mirror; a first optical coupler in optical communication with the first secondary mirror; and a first cavity length; and a second cavity including: a second primary mirror; a second secondary mirror; a second optical coupler; and a second cavity length.Type: GrantFiled: December 21, 2017Date of Patent: July 16, 2019Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCEInventors: Gordon Shaw, Jacob Taylor, Ryan Wagner, Felipe Guzman
-
Patent number: 10285943Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: GrantFiled: December 2, 2011Date of Patent: May 14, 2019Assignee: GreenMark Biomedical Inc.Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Ryan Wagner, Aareet Krsna Ganesh Shermon, Abdel Rahman Elsayed, Juewen Liu
-
Publication number: 20190033187Abstract: An optomechanical reference includes a basal member; a flexure that includes: a floating link; a first flexural member; and a second flexural member such that: the floating link is moveably disposed; a first stator; a second stator; a first cavity including: a first primary mirror; a first secondary mirror; a first optical coupler in optical communication with the first secondary mirror; and a first cavity length; and a second cavity including: a second primary mirror; a second secondary mirror; a second optical coupler; and a second cavity length.Type: ApplicationFiled: December 21, 2017Publication date: January 31, 2019Inventors: Gordon Shaw, Jacob Taylor, Ryan Wagner, Felipe Guzman
-
Publication number: 20130337065Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: ApplicationFiled: December 2, 2011Publication date: December 19, 2013Applicant: ECOSYNTHETIX LTD.Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Ryan Wagner, Aareet Ganesh Shermon, Abdel Rahman Elsayed, Juewen Liu
-
Publication number: 20130090467Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: ApplicationFiled: September 13, 2012Publication date: April 11, 2013Applicant: ECOSYNTHETIX LTD.Inventors: Steven BLOEMBERGEN, Ian J. MCLENNAN, Nathan JONES, Ryan WAGNER, Aareet Krsna GANESH SHERMON, Abdel Rahman ELSAYED, Juewen LIU
-
Publication number: 20120141551Abstract: A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable.Type: ApplicationFiled: December 2, 2011Publication date: June 7, 2012Applicant: ECOSYNTHETIX LTD.Inventors: Steven BLOEMBERGEN, Ian J. MCLENNAN, Nathan JONES, Ryan WAGNER, Aareet Krsna GANESH SHERMON, Abdel Rahman ELSAYED, Juewen LIU